Veterinary Medicines

V.M.D. Tiamulin 100 mg/g gyógypremix sertések részére A.U.V.

Authorised
  • Tiamulin hydrogen fumarate
Download as PDF

Product identification

Medicine name:
V.M.D. Tiamulin 100 mg/g gyógypremix sertések részére A.U.V.
Active substance:
  • Tiamulin hydrogen fumarate
Target species:
  • Pig
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
  • Pharmateka Preventive Kft.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 1/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 1/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."